Free Trial
NYSEARCA:MLPO

Credit Suisse S&P MLP Index ETN (MLPO) Price, Holdings, & News

$14.90 -0.19 (-1.26%)
As of 11/7/2023

About Credit Suisse S&P MLP Index ETN (NYSEARCA:MLPO)

Key Stats

Today's Range
$14.50
$15.70
50-Day Range
$14.90
$14.90
52-Week Range
$9.61
$48.80
Volume
3,400 shs
Average Volume
3,642 shs
Market Capitalization
$33.90 million
Assets Under Management
$30.48 thousand
Dividend Yield
0.00%
Net Expense Ratio
0.95%
Aggregate Rating
N/A

ETF Overview

Credit Suisse S&P MLP Index ETN Expenses

TypeMLPOEnergy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.00%0.62%0.56%0.51%0.53%
Other Expenses0.00%0.52%0.56%0.59%0.56%
Total Expense0.00%0.77%0.76%0.74%0.73%
Fee Waiver0.00%-0.32%-0.66%-0.71%-0.63%
Net Expense0.95%0.74%0.63%0.58%0.60%
Receive MLPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Credit Suisse S&P MLP Index ETN and its competitors with MarketBeat's FREE daily newsletter.

MLPO ETF News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Barclays ETN+ Select MLP ETN (ATMP)
Credit Suisse S&P MLP Index ETN (MLPO)
See More Headlines

MLPO ETF - Frequently Asked Questions

Credit Suisse S&P MLP Index ETN's stock was trading at $14.90 at the beginning of the year. Since then, MLPO shares have increased by 0.0% and is now trading at $14.90.

Shares of MLPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Credit Suisse S&P MLP Index ETN investors own include Itron (ITRI), PennantPark Floating Rate Capital (PFLT), Zumiez (ZUMZ), Align Technology (ALGN), Akorn (AKRX), Akebia Therapeutics (AKBA) and Aimmune Therapeutics (AIMT).

Fund Details

Issuer
Credit Suisse
Fund Name
Credit Suisse S&P MLP ETN
Tax Classification
Exchange-Traded Note
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:MLPO
Inception Date
12/2/2014
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P MLP Index
Category
Sector
Focus
Energy
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$30.48 thousand
Average Daily Volume
$2.82 thousand
Discount/Premium
-19.47%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
None

Miscellaneous

Beta
N/A
Creation Unit
50,000
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSEARCA:MLPO) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners